MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The effects of sensory reward cues on risky decision making in Parkinson’s disease

    M. Cherkasova, P. Surathi, S. Yeung, AJ. Stoessl, M. McKeown, S. Appel-Cresswell, C. Winstanley, J. Barton (Vancouver, BC, Canada)

    Objective: To evaluate the effects of sensory reward cues on risky decision making in unmedicated and medicated Parkinson’s disease (PD). Background: Cue reactivity may play…
  • 2018 International Congress

    Frontal midline theta activity is reduced during cognitive control in Parkinson’s disease

    A. Singh, S. Richardson, N. Narayanan, J. Cavanagh (Iowa City, IA, USA)

    Objective: To investigate the role of frontal theta oscillation during cognitive control in Parkinson's disease (PD). Background: Mid-frontal theta activity underlies cognitive control. These 4-8…
  • 2018 International Congress

    The Association Between Inhibitory Control and Freezing of Gait Severity in Parkinson’s Disease

    E. Bayram, S. Banks, J. Longhurst, B. Bluett (Las Vegas, NV, USA)

    Objective: To investigate the relationship between inhibitory control and freezing of gait (FOG) severity in Parkinson’s disease (PD). Background: Inhibition deficits play a role in…
  • 2018 International Congress

    Affective Theory of Mind Impaired in Parkinson’s Disease: Negative- and Neutral- specific impairments of Emotion State Decoding

    C.H. Tan, S.C. Tu, R.L. Yu (Kaohsiung, Taiwan)

    Objective: The primary aim of this study was to investigate whether the ability to interpret positive, negative, or neutral emotion from a pair of photographed…
  • 2018 International Congress

    Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative

    K. Wyman-Chick, D. Weintraub, P. Martin, L. Erickson, M. (Saint Paul, MN, USA)

    Objective: Compare cognitive performance in participants with Parkinson Disease (PD) utilizing published normative data versus age-stratified norms from the Parkinson’s Progression Marker Initiative (PPMI) healthy…
  • 2018 International Congress

    Predictive factors of fast cognitive decline in Parkinson’s disease after subthalamic stimulation: Myth or reality?

    F. Fluchere, F. Ory-Magne, M. Anheim, V. Rousseau, A. Eusebio, O. Lagha Boukbiza, B. Lemesle, T. Witjas, N. Longato, C. Tranchant, C. Brefel-Courbon, JP. Azulay (Marseille, France)

    Objective: To identify pre-operative factors of fast cognitive decline after subthalamic nucleus stimulation (STN DBS) in Parkinson’s disease (PD). Background: Cognitive outcome after STN DBS…
  • 2018 International Congress

    Resting-state fMRI in Parkinson’s disease patients with cognitive impairment: A meta-analysis

    A. Wolters, S. vd Weijer, A. Leentjens, A. Duits, H. Jacobs, M. Kuijf (Maastricht, Netherlands)

    Objective: To evaluate the patterns and magnitude of functional connectivity in resting-state brain networks in patients with Parkinson’s disease and cognitive impairment by pooling data…
  • 2018 International Congress

    Selection of antiparkinson drug and cognition in Japanese Parkinson Disease patients

    K. Konaka, Y. Kajiyama, R. Gajanan, M. Mihara, N. Hattori, H. Mochizuki (Suita, Japan)

    Objective: We attempted to analyze the correlation between dementia and internal medicine furthermore by elucidating the relevance to the frequently administered combination of antiparkinson drug.…
  • 2018 International Congress

    An analysis of cortical thickness in early Parkinson’s disease patients with cognitive impairment

    M. Mei, K. Nie, Y. Gao, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: To explore a possible relation between the changes of cortical thickness and cognitive deficits in patients with Parkinson’s disease (PD). Background: Cognitive impariment usually…
  • 2018 International Congress

    Plasma levels of vitamin D in patients with Parkinson’s disease: Correlation with Mini Mental State Examination and disease duration

    M. Barichella, L. Lorio, C. Bolliri, A. Giana, V. Ferri, G. Pinelli, E. Cassani, S. Caronni, C. Esposito, G. Riboldazzi, A. Maras, A. Perretti, F. Del Sorbo, P. Amadeo, R. Cilia, E. Cereda, G. Pezzoli (Milan, Italy)

    Objective: The aim of the study is to evaluate the plasma levels of 25(OH) D in PD, correlating these values with the cognitive function and…
  • « Previous Page
  • 1
  • …
  • 1522
  • 1523
  • 1524
  • 1525
  • 1526
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley